Peer Reviewed Publications
The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors, American Economic Journal: Applied Economics 2012 4(3): 116-137.
The Doctor Might See You Now: Supply Side Effects of Public Health Insurance Expansions, American Economic Journal: Economic Policy 2012 4(3): 190-217.
Can Celebrity Endorsements Affect Political Outcomes? Evidence from the 2008 U.S. Democratic Presidential Primary (with Timothy J. Moore), The Journal of Law, Economics, and Organization, 2013, 29(2): 355-384.
Giving Mom a Break: The Impact of Higher EITC Payments on Maternal Health (with William Evans), American Economic Journal: Economic Policy, 2014, 6(2): 258-290.
Demand Spillovers, Combative Advertising, and Celebrity Endorsements, American Economic Journal: Applied Economics, 2014, 6(2); 76-104.
The Market Impacts of Product Patents in Developing Countries: Evidence from India (with Mark Duggan and Aparajita Goyal), American Economic Review, 2016, 106(1): 99-135
Investment Subsidies and the Adoption of Electronic Medical Records in Hospitals, (with David Dranove, Chris Ody, and Bingyang Li), Journal of Health Economics, 44: 309-319.
The White/Black Educational Gap, Stalled Progress, and the Long Term Consequences of the Emergence of Crack Cocaine Markets, (with William Evans and Timothy J. Moore), forthcoming The Review of Economics and Statistics, February, 2015.
Early Impact of the Affordable Care Act on Emergency Department Use, (with John Graves, Tal Gross, and Matthew Notowidigdo), revise and resubmit Annals of Internal Medicine
Permanent Working Papers
Empirical Evidence on the Value of Pharmaceuticals, (with Mark Duggan), in The [Oxford]
Handbook of the Economics of the Biopharmaceutical Industry, 2012.
Starbucks: A Story of Growth, (with Jen Brown and Meghan Busse), 2011. Kellogg Case #5-211-259.
The Global Aircraft Manufacturing Industry, 2002-2011 (with Jen Brown), 2012. Kellogg Case #5-312-505.
Sovaldi: Pricing a Breakthrough Drug, (with Meghan Busse), 2015, Kellogg Case.